Sign in
TerminatedNo phase

Identification of Human Biomarkers Predictive of Diabetes Remission in Type 2 Diabetes Patient (BARIAKINES)

Key facts

Who runs it
University Hospital, Toulouse
Where
France1 site in 1 countryChoose a country to see its sites
Trial code
Status
Terminated
People taking part
23 people enrolled
Started
27 Feb 2023
Ended
27 Aug 2025
Type of study
Interventional
Treatments tested
  • blood samples
  • collection of body tissues
  • routine care procedure
Record updated
12 May 2026
Why it stopped
Inclusion difficulties

Who can take part

Age
18 years to 70 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Obese patients of at least grade 2 (body mass index ≥ 35 kg/m²)
  • Type 2 diabetics
  • About to undergo bariatric surgery at the Toulouse University Hospital
  • Affiliated or beneficiaries of a social security plan
  • Having provided a free, informed and written consent, signed

Who cannot take part

  • Type 1 diabetic subjects or Maturity-Onset Diabetes of the Youth
  • Pregnant and breastfeeding women
  • Vulnerable persons as defined in the Public Health Code: protected adults (guardianship, curators), unable to express their consent

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study focuses on identifying potentially predictive human circulating adipocyte and muscle biomarkers of diabetes remission after bariatric surgery in obese type 2 diabetic (T2D) subjects.

The group in the trial

  • study armTreatment being tested

    This arm consists of obese patients with type 2 diabetes who are scheduled for bariatric surgery.

    Treatment: blood samples, collection of body tissues, and routine care procedure

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Identification of Human Circulating Adipocyte and Muscle Biomarkers Potentially Predictive of Diabetes Remission After Bariatric Surgery in Obese and Type 2 Diabetic Subjects.
Record updated
12 May 2026